| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average Target Price on ASTELLAS PHARMA INC. |
|
|
|
Financial data source
© 2020 S&P Global Market Intelligence
|
|
|
Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million |
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
12 |
| Average target price |
2 275,00 JPY |
| Last Close Price |
1 486,00 JPY |
| Spread / Highest target |
81,7% |
| Spread / Average Target |
53,1% |
| Spread / Lowest Target |
14,4% |
Consensus revision (last 18 months)
|
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
